Janux Therapeutics (JANX) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.51
-0.38
-0.24
-0.11

Details

Expected EPS
-0.327325
Actual EPS
-0.51
Surprise EPS
-0.18
Surprise Percent
-55.81%

Description

⁨Janux Therapeutics⁩ (⁦JANX⁩) has reported earnings of ⁦-0.51⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts